Tanzanian Royalty Exploration Corp  

(Public, NYSEMKT:TRX)   Watch this stock  
Find more results for NYSEAMEX:TRX
-0.091 (-30.81%)
Feb 5 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.17 - 0.30
52 week 0.17 - 0.65
Open 0.27
Vol / Avg. 1.51M/76,031.00
Mkt cap 22.49M
P/E     -
Div/yield     -
EPS -0.06
Shares 107.90M
Beta 1.74
Inst. own 12%

Key stats and ratios

Q4 (Nov '15) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -8.80% -16.99%
Return on average equity -9.98% -18.80%
Employees 38 -
CDP Score - -


Scotia Plaza; 40 King St W 44th Floor 4100
+1-604-6964236 (Phone)
+1-604-5362529 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Tanzanian Royalty Exploration Corporation is engaged in the exploration and development of mineral property interests. The Company’s mineral properties are located in United Republic of Tanzania. Its subsidiaries include Tanzania American International Development Corporation 2000 Limited (Tanzam), Tancan Mining Co. Limited (Tancan), Buckreef Gold Company Ltd. (Buckreef) and Northwestern Base Metals Company Limited (NWBM). The Company explores or acquires gold or other precious metal concessions through its own efforts or through the efforts of its subsidiaries. The Company’s mineral interests in Tanzania are initially held under prospecting licenses granted pursuant to the Mining Act, 2010 (Tanzania) for a period of up to four years, and are renewable two times for a period of up to two years each. Through its wholly-owned subsidiary, Tanzam, the Company holds a 55% interest in the joint venture company, Buckreef Gold Company Limited, with Stamico holding the remaining 45%.

Officers and directors

Joseph K. Kahama Chairman of the Board, Chief Operating Officer
Bio & Compensation  - Reuters
James E. Sinclair President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
Marco Guidi Chief Financial Officer
Bio & Compensation  - Reuters
Rosalind Morrow Director
Bio & Compensation  - Reuters
Norman M. Betts Ph.D. Independent Director
Age: 59
Bio & Compensation  - Reuters
William M. Harvey Ph.D. Independent Director
Bio & Compensation  - Reuters
Abdulkarim Hamisi Mruma Ph.D. Independent Director
Bio & Compensation  - Reuters
Ulrich E. Rath Independent Director
Bio & Compensation  - Reuters